Convalescent plasma has a long history in treatment of infectious diseases – being used when other therapies are available .The use of plasma from patients who have recovered from COVID-19 was used similarly as it can neutralize viral particles and hence help patient care. But many randomized controlled trials have now been completed and it is time now for using evidence to inform not only clinical care but also future research.
The International Severe Acute Respiratory and emerging Infection Consortium is organizing a seminar titled “Use of convalescent plasma in patients hospitalised with COVID-19” as a part of the Oxford University Tropical Medicine Seminar . The seminar is on Jun 10, 2021, 13:30 -14:30 hours Indian Standard Time.
The talk will have presentation’s from Dr Aparna Mukherjee (ICMR) and Professor Peter Horby ( Oxford University) and Dr Soumyadeep Bhaumik (The George Institute for Global Health, India). The seminar is moderated by Bharath Kumar Tirupakuzhi Vijayaraghavan (Apollo Hospitals, India)
Dr Soumyadeep Bhaumik will talk about ” From trials to the bedside: convalescent plasma during the COVID-19 pandemic”
Abstract of talk
The use of convalescent plasma in hospitalized COVID-19 patients has started from the beginning of the pandemic. However, during the second wave of the COVID-19 pandemic – with a failing health system , with exhausted doctors and desperate patients – this meant widespread irrational use . Patient and care-givers had to run pillar-to-post to secure plasma from COVID-survivors. The national guidelines remained unchanged and many doctors were confident about its utility . I will discuss the sum-total of evidence (from a systematic review), discuss about how confident we are about the results (through GRADE), and put it in the evidence-to-decision framework in the Indian context. I will also touch on problems in our current guidelines which exist in form of mere flowcharts.
Event is free to attend but requires pre-registration: Click